IL162714A0 - Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis - Google Patents

Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis

Info

Publication number
IL162714A0
IL162714A0 IL16271403A IL16271403A IL162714A0 IL 162714 A0 IL162714 A0 IL 162714A0 IL 16271403 A IL16271403 A IL 16271403A IL 16271403 A IL16271403 A IL 16271403A IL 162714 A0 IL162714 A0 IL 162714A0
Authority
IL
Israel
Prior art keywords
metastasis
cancer invasion
therapy
prevention
synthetic peptides
Prior art date
Application number
IL16271403A
Other languages
English (en)
Original Assignee
Matthias Rath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matthias Rath filed Critical Matthias Rath
Publication of IL162714A0 publication Critical patent/IL162714A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL16271403A 2002-01-23 2003-01-23 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis IL162714A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35131702P 2002-01-23 2002-01-23
PCT/EP2003/000659 WO2003062413A1 (en) 2002-01-23 2003-01-23 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis

Publications (1)

Publication Number Publication Date
IL162714A0 true IL162714A0 (en) 2005-11-20

Family

ID=27613485

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16271403A IL162714A0 (en) 2002-01-23 2003-01-23 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis

Country Status (22)

Country Link
US (1) US8012935B2 (lv)
EP (1) EP1468085B1 (lv)
JP (1) JP2005515262A (lv)
KR (1) KR20040077764A (lv)
CN (2) CN1622992A (lv)
AT (1) ATE425247T1 (lv)
BR (1) BR0302819A (lv)
CA (1) CA2472775A1 (lv)
DE (1) DE60326539D1 (lv)
EE (1) EE200400030A (lv)
ES (1) ES2324027T3 (lv)
HR (1) HRP20040732A2 (lv)
IL (1) IL162714A0 (lv)
LV (2) LV13289B (lv)
MX (1) MXPA04007170A (lv)
NO (1) NO20034146L (lv)
NZ (1) NZ533738A (lv)
PL (1) PL209827B1 (lv)
RU (1) RU2346043C2 (lv)
WO (1) WO2003062413A1 (lv)
YU (1) YU76403A (lv)
ZA (1) ZA200405328B (lv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2856598B1 (fr) * 2003-06-25 2005-10-28 Inst Nat Sante Rech Med Peptides derives de la proteine mmp-2 et leur utilisation en immunotherapie antitumorale
JP4911950B2 (ja) * 2005-11-07 2012-04-04 晃 伊東 Ｍｍｐ−１の部分ペプチドを用いた癌浸潤・転移阻害薬
EP2403508B1 (en) * 2009-03-06 2015-10-28 Université Paris Descartes Method of treating cancer employing gingival fibroblast conditioned medium
US8593732B1 (en) * 2010-01-23 2013-11-26 Lightsmyth Technologies, Inc. Partially metallized total internal reflection immersion grating
US8003110B1 (en) * 2011-01-24 2011-08-23 Matthias W. Rath Metalloproteinase oligopeptides and their therapeutic use
EP2649985A1 (en) * 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (III)
US20140017267A1 (en) * 2012-07-13 2014-01-16 Matthias W Rath Metalloproteinase oligopeptides and their therapeutic use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280106A (en) 1988-05-20 1994-01-18 Liotta Lance A Matrix metalloproteinase peptides: role in diagnosis and therapy
GB8817075D0 (en) * 1988-07-18 1988-08-24 Raychem Ltd Oscillation suppressor
US5646027A (en) * 1994-09-08 1997-07-08 Warner-Lambert Company Process for the production of gelatinase catalytic domain protein
ES2559317T3 (es) 1999-10-29 2016-02-11 Glaxosmithkline Biologicals Sa Péptidos antigénicos de Neisseria

Also Published As

Publication number Publication date
EP1468085B1 (en) 2009-03-11
NO20034146L (no) 2003-10-28
PL209827B1 (pl) 2011-10-31
ES2324027T3 (es) 2009-07-29
ZA200405328B (en) 2006-03-29
RU2004125599A (ru) 2005-07-10
NZ533738A (en) 2006-03-31
JP2005515262A (ja) 2005-05-26
HRP20040732A2 (en) 2005-06-30
LV13289B (en) 2005-11-20
US20030139345A1 (en) 2003-07-24
PL371254A1 (en) 2005-06-13
MXPA04007170A (es) 2004-10-29
CN1622992A (zh) 2005-06-01
US8012935B2 (en) 2011-09-06
CA2472775A1 (en) 2003-07-31
ATE425247T1 (de) 2009-03-15
RU2346043C2 (ru) 2009-02-10
LV13419B (en) 2006-09-20
DE60326539D1 (de) 2009-04-23
KR20040077764A (ko) 2004-09-06
WO2003062413A1 (en) 2003-07-31
YU76403A (sh) 2006-05-25
CN101007844A (zh) 2007-08-01
EP1468085A1 (en) 2004-10-20
EE200400030A (et) 2004-04-15
NO20034146D0 (no) 2003-09-17
BR0302819A (pt) 2004-04-27

Similar Documents

Publication Publication Date Title
MXPA04001033A (es) Compuesto de sanado para heridas y anti-cancer.
MX2009008270A (es) Polipeptido novedoso que tiene actividad anti-tumoral.
MX2008009493A (es) Peptido novedoso y uso del mismo.
MXPA01007956A (es) Polipeptido antimicrobiano/neutralizador de endotoxina.
IL160897A0 (en) Human coagulation factor vii polypeptides
AU2003246676A8 (en) Antibodies anti-c5 component of the complement system and their use
HRP20050585A2 (en) Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof
TW200501976A (en) Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto
DE60138558D1 (de) Peptid aus hsp70 welches nk zellaktivtät stimuliert und seine verwendung
IL161319A0 (en) Use of thymulin-like peptides for making pain-relieving medicines
EP4306123A3 (en) Saposin-a derived peptides and uses thereof
IL162714A0 (en) Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis
RU2014134287A (ru) Бифункциональный пептид
LT2004079A (en) Sythetic peptides and uses therof for the prevention and therapy of cancer invasion and metastasis
FR2858234B1 (fr) Nouvel agent anti-angiogenique et son utilisation, notamment dans le cadre du traitement des cancers
NO20016341L (no) Inhibitorer for integrinet <alfa>v<beta>6
PT938329E (pt) Composicao de tlp imunogenica
ATE544779T1 (de) Neue, die migration dendritischer zellen induzierende polypeptide, sowie medikamente und pharmazeutische zusammensetzungen, die diese enthalten
WO2002053172A3 (en) Use of matrix metalloproteinase peptide substrate to lower the rate of extracellular matrix turnover
ATE417061T1 (de) Scorpionpeptid als blutdrucksenkendes mittel
TH57872B (th) สารยับยั้งของอินทีกริน อัลฟานู เบตา6
ATE400288T1 (de) Peptide mit hohem cysteingehalt
ATE305478T1 (de) Topoisomerase-ii inhibitoren
AU2003205658A1 (en) Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis